Armistice Capital, LLC Intellipharmaceutics International Inc. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$0.21 - $2.55 $180,600 - $2.19 Million
-860,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$2.4 - $5.3 $2.06 Million - $4.56 Million
860,000 New
860,000 $2.31 Million

About Intellipharmaceutics International Inc.

IPCIF Quotes by TradingView
  • Ticker IPCIF
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,092,700
  • Market Cap $4.96M
  • Description
  • Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in...
More about IPCIF
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email